The investigators observed a statistically significant relapse rate among those discontinuing medication for ADHD, which remained significant in subgroup analyses of both age groups.
All articles by Laurel Ranger
Excess mortality occurred as the result of a number of causes, including overdose, injuries, and both infectious and noncommunicable diseases.
Patients with bipolar disorder experienced significant reductions in sleep efficiency, which was not the case in patients with schizophrenia, although effect sizes for bipolar disorder were smaller overall.
The prevalence of autism spectrum disorder has been increasing over the past few decades and depending on the region, it is estimated to occur in 1% to 2% of children.
In patients with Huntington disease, higher levels of functional impairment and current alcohol consumption were significantly correlated with missing work in multivariate logistic regression analyses.
Depression contributed to elevated ratings in patients with MDD on items related to perceived inability to cope with the negative consequences of disturbed sleep and reported tendency to cancel social plans after poor sleep.
The results of the study point to the validity of the Research Domain Criteria initiative and suggest that neuroimaging findings may not be specific to certain psychiatric disorders.
After controlling for depression, irritability, and anxiety, the investigators found no direct effect of ADHD symptoms on suicidality.
Anna S. Urrila, MD and colleagues sought to explore whether sleep symptoms in adolescents with MDD were associated with long-term outcomes.
Behavioral variant frontotemporal dementia, a neurodegenerative disease that affects the frontal and anterior temporal lobes, results in disordered socioemotional behavior.
The United States has a rapidly ageing population, and 14 million people are projected to live with dementia by 2050.
More frequent manic/mixed and depressive episodes were associated with an increased risk for Parkinson disease.
This noninferiority trial showed no more chronic sleep loss or sleepiness across trial days among interns in flexible programs than among those in standard programs.
As federal healthcare reform has expanded medical insurance to millions of people, hospitals have an increasing role in improving community health.
Gerontologists, practicing ethicists, policymakers, and health practitioners should consider the structural conditions of long-term care that both foster aggression and constrain prevention efforts, according to this commentary.
Researchers have proposed a model that can explain the degree of depression in Parkinson disease, using imaging and genetics data.
Reduced fetal growth was associated with a small but significant increase in the general risk for psychiatric and neurodevelopmental disorders.
Clinicians have a responsibility to engage in initiatives that improve the quality of health information available online.
Assuming blame for a medical error may help patients and families heal.
Hearing loss affects more than 50% of Americans 60 years or older.
Approximately 5.5 million Americans have Alzheimer disease or dementia.
Investigators sought to determine the risk for serotonin syndrome with concomitant use of triptans and SSRI or SNRI antidepressants after the FDA issued an advisory warning.
In some patients, surgical trigger site deactivation may treat migraine effectively and relieve symptoms substantially.
Investigators sought to determine whether brain pattern metabolic alterations in PD and FDG-PET SPM could predict dementia risk.
The use of subthalamic stimulation may be beneficial in managing psychobehavioral manifestations of Parkinson disease.
Conflict-of-interest statements should be included in medical journals in order to enhance transparency.
Due to inadequate blinding in clinical trials, the benefits associated with medical cannabis therapy may be overestimated.
Male gender, excessive daytime sleepiness, and presence of metabolic syndrome were among the risk factors for obstructive sleep apnea in major depression.
CPAP therapy shows to reduce PTSD symptoms in veterans with PTSD and OSA.
It is determined that the Value-Based Payment Modifier program is not linked with differences in performance between practices serving higher or lower-risk patients.